Ved længerevarende behandling igennem mere end 2 år, anbefales jævnlige revurderinger med henblik på at bekræfte, at den valgte behandling fortsat er relevant for patienten.
With prolonged treatment for more than 2 years, regular reassessment is recommended to confirm that continuing the selected therapy remains appropriate for the patient.